Amos Sakwe to Antineoplastic Agents
This is a "connection" page, showing publications Amos Sakwe has written about Antineoplastic Agents.
Connection Strength
0.886
-
Vuong NB, Korolkova OY, Izban MG, Sakwe NI, McIntosh AR, Ball DD, Black PJ, Edwards AD, Ballard BR, Adunyah SE, Sakwe AM. Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer. Int J Mol Sci. 2026 Mar 31; 27(7).
Score: 0.529
-
Koumangoye RB, Nangami GN, Thompson PD, Agboto VK, Ochieng J, Sakwe AM. Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors. Mol Cancer. 2013 Dec 19; 12(1):167.
Score: 0.226
-
Gonzalez SB, Shivam P, Ball D, Ajisegiri SB, Osi I, Misra S, Mutchler AL, Lindsey ML, Martin PM, Sakwe AM, Nde PN. Bugs as drugs: parasite biomolecules as novel therapeutics against breast cancer. Am J Physiol Cell Physiol. 2026 Apr 01; 330(4):C1067-C1080.
Score: 0.132